Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
grade F 124.78 -1.04% -1.31
BLUE closed down 1.04 percent on Monday, October 15, 2018, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical BLUE trend table...

Date Alert Name Type % Chg
Oct 15 New 52 Week Closing Low Bearish 0.00%
Oct 15 Lower Bollinger Band Walk Weakness 0.00%
Oct 15 New 52 Week Low Weakness 0.00%
Oct 15 Below Lower BB Weakness 0.00%
Oct 15 Down 3 Days in a Row Weakness 0.00%
Oct 15 Down 4 Days in a Row Weakness 0.00%
Oct 15 Lower Bollinger Band Touch Weakness 0.00%
Oct 15 Oversold Stochastic Weakness 0.00%
Oct 12 New 52 Week Closing Low Bearish -1.04%
Oct 12 Slingshot Bearish Bearish Swing Setup -1.04%

Older signals for BLUE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Is BLUE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 236.17
52 Week Low 120.02
Average Volume 614,943
200-Day Moving Average 174.7638
50-Day Moving Average 149.7332
20-Day Moving Average 138.123
10-Day Moving Average 134.652
Average True Range 6.8324
ADX 32.78
+DI 11.5613
-DI 30.0758
Chandelier Exit (Long, 3 ATRs ) 128.6778
Chandelier Exit (Short, 3 ATRs ) 140.5172
Upper Bollinger Band 151.1881
Lower Bollinger Band 125.0579
Percent B (%b) -0.01
BandWidth 18.918066
MACD Line -6.4947
MACD Signal Line -5.2919
MACD Histogram -1.2028
Fundamentals Value
Market Cap 5.69 Billion
Num Shares 45.6 Million
EPS -7.33
Price-to-Earnings (P/E) Ratio -17.02
Price-to-Sales 233.66
Price-to-Book 5.18
PEG Ratio 0.31
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 135.25
Resistance 3 (R3) 134.83 130.91 133.51
Resistance 2 (R2) 130.91 128.25 131.13 132.92
Resistance 1 (R1) 127.85 126.60 125.89 128.27 132.34
Pivot Point 123.93 123.93 122.96 124.15 123.93
Support 1 (S1) 120.87 121.27 118.91 121.29 117.22
Support 2 (S2) 116.95 119.62 117.17 116.64
Support 3 (S3) 113.89 116.95 116.06
Support 4 (S4) 114.31